Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China-Reference-Cited by-同舟云学术

Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China

Published:2022-08-28 Issue: Volume: Page:
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Wen Qing,Ge Jingjing,Lei Yaxin,Zhang Yue,Kong Xiaoshuang,Wang Wenhua,Hou Huting,Wang Zeyuan,Qian Siyu,Ding Mengjie,Dong Meng,Zhu Linan,Zhang Mingzhi,Zhang Xudong,Chen Qingjiang

Funder

National Natural Science Foundation of China

Henan Medical Science and Technology Research Project

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-022-04321-6.pdf

Reference45 articles.

1. Allen PB, Gordon LI (2016) PD-1 blockade in Hodgkin’s lymphoma: learning new tricks from an old teacher. Expert Rev Hematol 9:939–949. https://doi.org/10.1080/17474086.2016.1235970

2. Armand P, Chen YB, Redd RA et al (2019) PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation. Blood 134:22–29. https://doi.org/10.1182/blood.2019000215

3. Böll B, Goergen H, Behringer K et al (2016) Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. Blood 127:2189–2192. https://doi.org/10.1182/blood-2015-11-681064

4. Brice P, de Kerviler E, Friedberg JW (2021) Classical Hodgkin lymphoma. Lancet 398:1518–1527. https://doi.org/10.1016/s0140-6736(20)32207-8

5. Bröckelmann PJ, Goergen H, Keller U et al (2020) Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin study group NIVAHL trial. JAMA Oncol 6:872–880. https://doi.org/10.1001/jamaoncol.2020.0750

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients;Cancers;2024-01-05

2. Born with Two Faces: Sequential development of Diffuse Large B-cell Lymphoma and Angioimmunoblastic T-cell Lymphoma with EBV positive and TET2 mutation;2023-12-26

3. Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma;Frontiers in Pharmacology;2023-08-23

4. The International Prognostic Score and HIV status predict red cell concentrate transfusion needs in Hodgkin lymphoma;Leukemia & Lymphoma;2022-12-23